Examkin

Question

Difficulty: Very hardPharmacologic Interventions

A 64-year-old man is brought to the emergency department by his daughter due to a 2-day history of worsening confusion, lethargy, and a reversed sleep-wake cycle. He has a history of decompensated cirrhosis secondary to non-alcoholic steatohepatitis and has had one prior episode of hepatic encephalopathy. His home medications include lactulose 30 mL three times daily, spironolactone 100 mg daily, and furosemide 40 mg daily. The daughter reports he has been highly compliant with his medications and has been having 3 to 4 soft bowel movements daily.

Vital signs are temperature 37.0°C (98.6°F), heart rate 98/min, blood pressure 100/60 mmHg, and respiratory rate 16/min. Physical examination reveals a lethargic man who is oriented only to person. Scleral icterus and spider angiomas are present. The abdomen is distended with shifting dullness. When the patient's arms are extended with wrists dorsiflexed, a coarse, flapping tremor is observed.

Laboratory studies show:
Sodium: 131 mEq/L
Potassium: 2.8 mEq/L
Chloride: 90 mEq/L
Bicarbonate: 34 mEq/L
Blood urea nitrogen: 52 mg/dL
Serum creatinine: 1.4 mg/dL (baseline 0.9 mg/dL)
Total bilirubin: 3.5 mg/dL
Albumin: 2.6 g/dL

Which of the following is the most appropriate initial pharmacologic intervention?

  1. Administer intravenous potassium chloride and withhold diureticsAnswer
  2. B
    Initiate oral rifaximin therapy
  3. C
    Increase the dose of lactulose to every 4 hours
  4. D
    Administer intravenous haloperidol
  5. E
    Administer intravenous albumin and empiric ceftriaxone

Answer

The most appropriate initial intervention is to administer intravenous potassium chloride and withhold the diuretic medications.
The correct intervention addresses the root cause of the patient's acute decompensation. This patient is suffering from hepatic encephalopathy precipitated by severe diuretic-induced hypokalemia and metabolic alkalosis. In the kidneys, hypokalemia stimulates the production of ammonia (NH3NH_3). Concurrently, metabolic alkalosis shifts the equilibrium between ammonium (NH4+NH_4^+) and ammonia (NH3NH_3) toward the uncharged NH3NH_3 state. Because NH3NH_3 is lipid-soluble, it readily crosses the blood-brain barrier, worsening encephalopathy. Since the patient is already achieving the therapeutic goal of 3 to 4 bowel movements per day on lactulose, the most critical next step is to reverse the metabolic precipitant by administering intravenous potassium chloride and holding his furosemide and spironolactone.

Step-by-Step Solution

1
Diagnose the acute presentation based on clinical findings.
The patient has altered mental status and asterixis in the setting of cirrhosis, confirming an acute exacerbation of hepatic encephalopathy (HE).
Establishing the primary clinical syndrome is necessary to guide the search for a specific precipitating cause.
2
Evaluate the patient's current HE management regimen and clinical response.
The patient is taking lactulose appropriately and having 3 to 4 bowel movements daily, indicating adequate baseline clearance of enteral ammonia.
Recognizing that baseline therapy is optimized suggests that a secondary, acute precipitating factor is driving the exacerbation.
3
Analyze laboratory data to identify precipitants for the encephalopathy.
Labs reveal severe hypokalemia (2.8 mEq/L2.8\text{ mEq/L}), metabolic alkalosis (bicarbonate 34 mEq/L34\text{ mEq/L}), and prerenal azotemia (BUN/Cr ratio > 20:1).
Electrolyte derangements and volume depletion are classic triggers for HE, commonly caused by over-diuresis in cirrhotic patients.
4
Determine the targeted pharmacologic intervention to reverse the identified precipitant.
The correct action is to rapidly replete potassium intravenously and immediately discontinue the offending loop and potassium-sparing diuretics.
Hypokalemia directly increases renal ammonia genesis, and alkalosis promotes the conversion of ammonium to membrane-permeable ammonia. Correcting these stops the pathological drive of the encephalopathy.

Key Concept

Hypokalemia and metabolic alkalosis, frequently induced by over-diuresis, are potent precipitants of hepatic encephalopathy. They increase renal ammonia (NH3NH_3) production and promote its passage across the blood-brain barrier. Management requires immediate potassium repletion and cessation of diuretics, rather than simply escalating ammonia-lowering therapies.
Rate this question

Topics

Pharmacologic Interventions

More questions from this topic